Reducing VEGFB accelerates NAFLD and insulin resistance in mice via inhibiting AMPK signaling pathway

OBJECTIVE: Vascular endothelial growth factor B (VEGFB) was regarded to improve lipid metabolism and reduce obesity-related hyperlipidemia. Whether VEGFB participates in lipid metabolism in nonalcoholic fatty liver disease (NAFLD) has not been clear yet. This study investigated the involvement of VE...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Rongrong, Li, Yuqi, Yang, Xueling, Hu, Yaorui, Yu, Haining, Li, Yana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338666/
https://www.ncbi.nlm.nih.gov/pubmed/35907871
http://dx.doi.org/10.1186/s12967-022-03540-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338666/
https://www.ncbi.nlm.nih.gov/pubmed/35907871
http://dx.doi.org/10.1186/s12967-022-03540-2

Ejemplares similares